OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
South Korea · Delayed Price · Currency is KRW 10,800
-2,970 (-21.57%)
At close: Apr 2, 2026
OPTUS Pharmaceutical Market Cap
OPTUS Pharmaceutical has a market cap or net worth of 190.58 billion as of April 2, 2026. Its market cap has increased by 74.79% in one year.
Market Cap
190.58B
Enterprise Value
151.76B
Revenue
87.16B
Ranking
n/a
PE Ratio
14.79
Stock Price
10,800.00
Market Cap Chart
Since November 15, 2013, OPTUS Pharmaceutical's market cap has increased from 80.94B to 190.58B, an increase of 135.47%. That is a compound annual growth rate of 7.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 190.58B | 56.98% |
| Dec 30, 2025 | 121.41B | 23.21% |
| Dec 30, 2024 | 98.53B | 14.66% |
| Dec 28, 2023 | 85.93B | -15.42% |
| Dec 29, 2022 | 101.60B | -9.40% |
| Dec 30, 2021 | 112.14B | -19.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GREEN CROSS WellBeing | 257.13B |
| DAE HWA Pharmaceutical | 248.91B |
| NOVAREX | 242.52B |
| High Tech Pharm | 216.39B |
| Vivozon Pharmaceutical | 158.56B |
| Kyung Dong Pharmaceutical | 147.64B |
| Organoidsciences | 144.89B |
| DongKoo Bio & Pharma | 137.10B |